ALX Oncology (ALXO) Short Interest Ratio & Short Volume → This Wall Street stock prediction just went viral (From Chaikin Analytics) (Ad) Free ALXO Stock Alerts $15.02 -0.15 (-0.99%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media ALX Oncology Short Interest DataCurrent Short Volume3,160,000 sharesPrevious Short Volume3,690,000 sharesChange Vs. Previous Month-14.36%Dollar Volume Sold Short$53.78 millionShort Interest Ratio / Days to Cover6.1Last Record DateApril 30, 2024Outstanding Shares52,100,000 sharesFloat Size27,580,000 sharesShort Percent of Float11.46%Today's Trading Volume321,855 sharesAverage Trading Volume455,336 sharesToday's Volume Vs. Average71% Short Selling ALX Oncology ? Sign up to receive the latest short interest report for ALX Oncology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatALXO Short Interest Over TimeALXO Days to Cover Over TimeALXO Percentage of Float Shorted Over Time Ad Chaikin AnalyticsThis Wall Street stock prediction just went viralPeople around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history.Watch just the first 5 minutes of his new prediction ALX Oncology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20243,160,000 shares $53.78 million -14.4%11.5%6.1 $17.02 4/15/20243,690,000 shares $47.56 million +18.3%13.5%8 $12.89 3/31/20243,120,000 shares $34.79 million +7.2%11.5%8 $11.15 3/15/20242,910,000 shares $32.88 million -16.4%10.7%7.7 $11.30 2/29/20243,480,000 shares $51.05 million -1.4%12.9%7.5 $14.67 2/15/20243,530,000 shares $59.27 million -2.5%13.1%7.8 $16.79 Get the Latest News and Ratings for ALXO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ALX Oncology and its competitors with MarketBeat's FREE daily newsletter. 1/31/20243,620,000 shares $52.16 million -1.9%13.2%8 $14.41 1/15/20243,690,000 shares $52.91 million -2.1%13.5%8.2 $14.34 12/31/20233,770,000 shares $56.14 million -6.7%13.8%6.5 $14.89 12/15/20234,040,000 shares $54.74 million +3.1%14.8%2.9 $13.55 11/30/20233,920,000 shares $30.73 million +0.5%17.6%2.9 $7.84 11/15/20233,900,000 shares $34.20 million +2.1%17.5%3.1 $8.77 10/31/20233,820,000 shares $27.50 million -2.1%20.8%3.2 $7.20 10/15/20233,900,000 shares $35.61 million +46.1%21.2%3.3 $9.13 9/30/20232,670,000 shares $12.82 million -11.9%14.5%2.4 $4.80 9/15/20233,030,000 shares $15.70 million -4.1%16.5%19.1 $5.18 8/31/20233,160,000 shares $13.46 million +5.0%17.2%16.6 $4.26 8/15/20233,010,000 shares $14.63 million +2.0%16.5%14.9 $4.86 7/31/20232,950,000 shares $18.02 million +1.0%16.5%14.1 $6.11 7/15/20232,920,000 shares $19.77 million -0.3%16.2%11.2 $6.77 6/30/20232,930,000 shares $22.00 million No Change16.2%9.9 $7.51 6/15/20232,930,000 shares $28.01 million No Change16.2%9.9 $9.56 5/31/20232,930,000 shares $19.54 million +2.1%16.1%9.3 $6.67 5/15/20232,870,000 shares $18.54 million -4.3%16.3%9.8 $6.46 4/30/20233,000,000 shares $17.82 million -23.9%17.0%10.6 $5.94 4/15/20233,940,000 shares $18.91 million +3.4%22.3%15.4 $4.80 3/31/20233,810,000 shares $17.22 million -4.3%21.7%16.9 $4.52 3/15/20233,980,000 shares $20.66 million +3.7%22.6%17.2 $5.19 2/28/20233,840,000 shares $25.42 million +5.2%21.9%22.1 $6.62 2/15/20233,650,000 shares $28.32 million -5.7%20.8%22.2 $7.76 1/31/20233,870,000 shares $35.99 million -4.4%22.1%22.1 $9.30 1/15/20234,050,000 shares $40.54 million -2.4%23.1%22.8 $10.01 12/30/20224,150,000 shares $46.77 million +0.2%23.7%24.3 $11.27 12/15/20224,140,000 shares $43.72 million -3.0%23.6%29.1 $10.56 11/30/20224,270,000 shares $47.40 million No Change24.3%29.3 $11.10 11/15/20224,270,000 shares $49.53 million -1.8%24.3%26.3 $11.60 10/31/20224,350,000 shares $52.81 million -1.1%23.9%25.5 $12.14 10/15/20224,400,000 shares $48.36 million -3.5%24.1%23.9 $10.99 9/30/20224,560,000 shares $43.64 million No Change25.0%22.6 $9.57 9/15/20224,560,000 shares $57.64 million +6.5%25.0%18.6 $12.64Wall Street legend who predicted 2021 tech crash issues new warning (Ad)People around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history.Watch his stock warning right here, 100% free of charge ALXO Short Interest - Frequently Asked Questions What is ALX Oncology's current short interest? Short interest is the volume of ALX Oncology shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 3,160,000 shares of ALXO short. 11.46% of ALX Oncology's shares are currently sold short. Learn More on ALX Oncology's current short interest. What is a good short interest ratio for ALX Oncology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALXO shares currently have a short interest ratio of 6.0. Learn More on ALX Oncology's short interest ratio. Which institutional investors are shorting ALX Oncology? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ALX Oncology: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for ALX Oncology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.46% of ALX Oncology's floating shares are currently sold short. Is ALX Oncology's short interest increasing or decreasing? ALX Oncology saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 3,160,000 shares, a drop of 14.4% from the previous total of 3,690,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ALX Oncology's float size? ALX Oncology currently has issued a total of 52,100,000 shares. Some of ALX Oncology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ALX Oncology currently has a public float of 27,580,000 shares. How does ALX Oncology's short interest compare to its competitors? 11.46% of ALX Oncology's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to ALX Oncology: Longboard Pharmaceuticals, Inc. (13.02%), Disc Medicine, Inc. (12.97%), Praxis Precision Medicines, Inc. (5.06%), Evolus, Inc. (9.69%), Arcturus Therapeutics Holdings Inc. (20.02%), Tango Therapeutics, Inc. (19.84%), Dianthus Therapeutics, Inc. (9.95%), Zentalis Pharmaceuticals, Inc. (24.64%), PureTech Health plc (0.02%), Aurinia Pharmaceuticals Inc. (8.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short ALX Oncology stock? Short selling ALXO is an investing strategy that aims to generate trading profit from ALX Oncology as its price is falling. ALXO shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ALX Oncology? A short squeeze for ALX Oncology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ALXO, which in turn drives the price of the stock up even further. How often is ALX Oncology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALXO, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: LBPH Short Interest IRON Short Interest PRAX Short Interest EOLS Short Interest ARCT Short Interest TNGX Short Interest DNTH Short Interest ZNTL Short Interest PRTC Short Interest AUPH Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ALXO) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersGold Set to EXPLODE!Gold Safe ExchangeRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap Sniper